Holen Sie sich die Stockscreener-App
1.99
9.94%
0.18
Handel nachbörslich:
2.00
0.01
+0.50%
Schlusskurs vom Vortag:
$1.81
Offen:
$1.84
24-Stunden-Volumen:
63,078
Relative Volume:
0.18
Marktkapitalisierung:
$2.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.78M
KGV:
-0.0466
EPS:
-42.6996
Netto-Cashflow:
$-4.67M
1W Leistung:
-9.95%
1M Leistung:
-61.61%
6M Leistung:
-94.49%
1J Leistung:
-96.57%
1-Tages-Spanne:
$1.84
$2.05
1-Wochen-Bereich:
$1.743
$2.17
52-Wochen-Spanne:
$1.743
$70.00
Clearmind Medicine Inc Stock (CMND) Company Profile
Firmenname
Clearmind Medicine Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CMND mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.99 | 2.71M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten
Clearmind regains Nasdaq compliance as shares maintain $1 minimum - Investing.com India
Clearmind Medicine Says Nasdaq Compliance Regained on Minimum Bid Price Rule - marketscreener.com
Clearmind Medicine regains compliance with Nasdaq minimum bid price rule - TipRanks
Clearmind regains Nasdaq compliance as shares maintain $1 minimum By Investing.com - Investing.com South Africa
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement - marketscreener.com
Clearmind Medicine highlights key 2025 achievements - MSN
Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stock - bollywoodhelpline.com
Clearmind advances AUD treatment as phase I/IIa trial progresses By Investing.com - Investing.com Nigeria
Clearmind advances AUD treatment as phase I/IIa trial progresses - Investing.com
Clearmind Medicine Inc. Reflects on Major Progress in 2025 Clinical Trials for CMND-100 Targeting Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth - Yahoo Finance
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - MSN
Cash from operating activities of Clearmind Medicine Inc. – MUN:CWY - TradingView — Track All Markets
Trading Recap: How strong is Clearmind Medicine Inc. stock balance sheetJuly 2025 Selloffs & Weekly Setup with ROI Potential - moha.gov.vn
How interest rate cuts could boost Clearmind Medicine Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - Улправда
Will Clearmind Medicine Inc. stock benefit from AI adoptionJuly 2025 Chart Watch & Comprehensive Market Scan Reports - Улправда
Why Clearmind Medicine Inc. stock remains on buy listsEarnings Trend Report & AI Powered Market Trend Analysis - DonanımHaber
Published on: 2025-12-19 05:54:25 - Улправда
Pretax income of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Free float of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Cash from financing activities of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets
Cost of goods sold of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Gross profit of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Long term debt to total assets ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Non-operating income (total) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating expenses (excl. COGS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Balance Sheet – LSX:A41YK5 - TradingView — Track All Markets
Price to cash flow ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Diluted net income available to common stockholders of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating cash flow per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
CapEx per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Enterprise value to EBITDA ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating margin % of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Total revenue of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Published on: 2025-12-18 16:01:28 - Улправда
Clearmind Medicine Inc. Cash Flow – LSX:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Earnings and Revenue – LSX:A41YK5 - TradingView — Track All Markets
Is Clearmind Medicine Inc. stock a top momentum playJuly 2025 Summary & Community Verified Trade Signals - Улправда
Number of employees of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Revenue Breakdown – LS:A41YK5 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Book value per share of Clearmind Medicine Inc. – BER:CWY - TradingView — Track All Markets
Net margin % of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets
Total debt per share of Clearmind Medicine Inc. – MUN:CWY - TradingView — Track All Markets
Enterprise value of Clearmind Medicine Inc. – BER:CWY - TradingView — Track All Markets
Operating margin % of Clearmind Medicine Inc. – BER:CWY - TradingView — Track All Markets
Finanzdaten der Clearmind Medicine Inc-Aktie (CMND)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):